Chapter/Section Purchase

1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neurological Biomarkers Sales Estimates and Forecasts 2017-2028
2.2 Global Neurological Biomarkers Revenue Estimates and Forecasts 2017-2028
2.3 Global Neurological Biomarkers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neurological Biomarkers Sales by Region
2.4.1 Global Neurological Biomarkers Sales by Region (2017-2022)
2.4.2 Global Sales Neurological Biomarkers by Region (2023-2028)
2.5 Global Neurological Biomarkers Revenue by Region
2.5.1 Global Neurological Biomarkers Revenue by Region (2017-2022)
2.5.2 Global Neurological Biomarkers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurological Biomarkers Sales by Manufacturers
3.1.1 Global Top Neurological Biomarkers Manufacturers by Sales (2017-2022)
3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurological Biomarkers in 2021
3.2 Global Neurological Biomarkers Revenue by Manufacturers
3.2.1 Global Neurological Biomarkers Revenue by Manufacturers (2017-2022)
3.2.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2021
3.3 Global Neurological Biomarkers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurological Biomarkers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurological Biomarkers Sales by Type
4.1.1 Global Neurological Biomarkers Historical Sales by Type (2017-2022)
4.1.2 Global Neurological Biomarkers Forecasted Sales by Type (2023-2028)
4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2017-2028)
4.2 Global Neurological Biomarkers Revenue by Type
4.2.1 Global Neurological Biomarkers Historical Revenue by Type (2017-2022)
4.2.2 Global Neurological Biomarkers Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2017-2028)
4.3 Global Neurological Biomarkers Price by Type
4.3.1 Global Neurological Biomarkers Price by Type (2017-2022)
4.3.2 Global Neurological Biomarkers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neurological Biomarkers Sales by Application
5.1.1 Global Neurological Biomarkers Historical Sales by Application (2017-2022)
5.1.2 Global Neurological Biomarkers Forecasted Sales by Application (2023-2028)
5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2017-2028)
5.2 Global Neurological Biomarkers Revenue by Application
5.2.1 Global Neurological Biomarkers Historical Revenue by Application (2017-2022)
5.2.2 Global Neurological Biomarkers Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2017-2028)
5.3 Global Neurological Biomarkers Price by Application
5.3.1 Global Neurological Biomarkers Price by Application (2017-2022)
5.3.2 Global Neurological Biomarkers Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neurological Biomarkers Market Size by Type
6.1.1 North America Neurological Biomarkers Sales by Type (2017-2028)
6.1.2 North America Neurological Biomarkers Revenue by Type (2017-2028)
6.2 North America Neurological Biomarkers Market Size by Application
6.2.1 North America Neurological Biomarkers Sales by Application (2017-2028)
6.2.2 North America Neurological Biomarkers Revenue by Application (2017-2028)
6.3 North America Neurological Biomarkers Market Size by Country
6.3.1 North America Neurological Biomarkers Sales by Country (2017-2028)
6.3.2 North America Neurological Biomarkers Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neurological Biomarkers Market Size by Type
7.1.1 Europe Neurological Biomarkers Sales by Type (2017-2028)
7.1.2 Europe Neurological Biomarkers Revenue by Type (2017-2028)
7.2 Europe Neurological Biomarkers Market Size by Application
7.2.1 Europe Neurological Biomarkers Sales by Application (2017-2028)
7.2.2 Europe Neurological Biomarkers Revenue by Application (2017-2028)
7.3 Europe Neurological Biomarkers Market Size by Country
7.3.1 Europe Neurological Biomarkers Sales by Country (2017-2028)
7.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurological Biomarkers Market Size by Type
8.1.1 Asia Pacific Neurological Biomarkers Sales by Type (2017-2028)
8.1.2 Asia Pacific Neurological Biomarkers Revenue by Type (2017-2028)
8.2 Asia Pacific Neurological Biomarkers Market Size by Application
8.2.1 Asia Pacific Neurological Biomarkers Sales by Application (2017-2028)
8.2.2 Asia Pacific Neurological Biomarkers Revenue by Application (2017-2028)
8.3 Asia Pacific Neurological Biomarkers Market Size by Region
8.3.1 Asia Pacific Neurological Biomarkers Sales by Region (2017-2028)
8.3.2 Asia Pacific Neurological Biomarkers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Neurological Biomarkers Market Size by Type
9.1.1 Latin America Neurological Biomarkers Sales by Type (2017-2028)
9.1.2 Latin America Neurological Biomarkers Revenue by Type (2017-2028)
9.2 Latin America Neurological Biomarkers Market Size by Application
9.2.1 Latin America Neurological Biomarkers Sales by Application (2017-2028)
9.2.2 Latin America Neurological Biomarkers Revenue by Application (2017-2028)
9.3 Latin America Neurological Biomarkers Market Size by Country
9.3.1 Latin America Neurological Biomarkers Sales by Country (2017-2028)
9.3.2 Latin America Neurological Biomarkers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurological Biomarkers Market Size by Type
10.1.1 Middle East and Africa Neurological Biomarkers Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neurological Biomarkers Revenue by Type (2017-2028)
10.2 Middle East and Africa Neurological Biomarkers Market Size by Application
10.2.1 Middle East and Africa Neurological Biomarkers Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neurological Biomarkers Revenue by Application (2017-2028)
10.3 Middle East and Africa Neurological Biomarkers Market Size by Country
10.3.1 Middle East and Africa Neurological Biomarkers Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Corporation Information
11.3.2 Quest Diagnostics Overview
11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Quest Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Quest Diagnostics Recent Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Overview
11.4.3 Abbott Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Recent Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Overview
11.5.3 Roche Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Roche Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Recent Developments
11.6 Illumina
11.6.1 Illumina Corporation Information
11.6.2 Illumina Overview
11.6.3 Illumina Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Illumina Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Illumina Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Corporation Information
11.7.2 Bio-Rad Laboratories Overview
11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Overview
11.8.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 QIAGEN Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 QIAGEN Recent Developments
11.9 Myriad RBM
11.9.1 Myriad RBM Corporation Information
11.9.2 Myriad RBM Overview
11.9.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Myriad RBM Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Myriad RBM Recent Developments
11.10 Cisbio Bioassays
11.10.1 Cisbio Bioassays Corporation Information
11.10.2 Cisbio Bioassays Overview
11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cisbio Bioassays Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cisbio Bioassays Recent Developments
11.11 Athena Diagnostics
11.11.1 Athena Diagnostics Corporation Information
11.11.2 Athena Diagnostics Overview
11.11.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Athena Diagnostics Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Athena Diagnostics Recent Developments
11.12 BGI
11.12.1 BGI Corporation Information
11.12.2 BGI Overview
11.12.3 BGI Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 BGI Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BGI Recent Developments
11.13 Wuxi APP
11.13.1 Wuxi APP Corporation Information
11.13.2 Wuxi APP Overview
11.13.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Wuxi APP Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Wuxi APP Recent Developments
11.14 Aepodia
11.14.1 Aepodia Corporation Information
11.14.2 Aepodia Overview
11.14.3 Aepodia Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Aepodia Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Aepodia Recent Developments
11.15 Proteome Sciences
11.15.1 Proteome Sciences Corporation Information
11.15.2 Proteome Sciences Overview
11.15.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Proteome Sciences Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Proteome Sciences Recent Developments
11.16 Genewiz
11.16.1 Genewiz Corporation Information
11.16.2 Genewiz Overview
11.16.3 Genewiz Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Genewiz Neurological Biomarkers Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Genewiz Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neurological Biomarkers Industry Chain Analysis
12.2 Neurological Biomarkers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurological Biomarkers Production Mode & Process
12.4 Neurological Biomarkers Sales and Marketing
12.4.1 Neurological Biomarkers Sales Channels
12.4.2 Neurological Biomarkers Distributors
12.5 Neurological Biomarkers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurological Biomarkers Industry Trends
13.2 Neurological Biomarkers Market Drivers
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints
14 Key Findings in The Global Neurological Biomarkers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer